Ercros Company Description

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain.

It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, caustic potash, caustic soda, chlorine chloroisocyanurates, dichloroethane, ercrosbio, hydrochloric acid, hydrogen peroxide, polyvinyl chloride, potassium carbonate, PVC compounds, sodium chlorate, sodium chlorite, sodium hypochlorite, sulfuric acid, and vinyl chloride.

The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding compunds, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing of particle, as well as resins, paints, and varnishes in the furniture and decoration industry; sockets and switches in the electrical components sector; and health and packaging items in the textile tanning industry.

The Pharmacy division engages in the production of raw materials and pharmaceutical intermediate products from antibiotic, anti-hypertensives, and anti-ulcer drugs.

This segment’s products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, fosfomycin calcium and sodium, fosfomycin trometamol, and fusidic acid.

The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

Ercros, S.A.

Country	Spain
Founded	1817
Industry	Industrial Inorganic Chemicals
Employees	1,318
CEO	Antonio Zabalza Marti

Contact Details

Address: Avinguda Diagonal, 593-595 Barcelona, 08014 Spain
Phone	34 934 39 30 09
Website	ercros.es

Stock Details

Ticker Symbol	CRS1
Exchange	Frankfurt Stock Exchange
Fiscal Year	January - December
Reporting Currency	EUR
SIC Code	2810

Key Executives

Name	Position
Antonio Zabalza Marti	Chief Executive Officer
Pedro Rodríguez Sánchez	Chief Financial Officer
Agustín Blasco	Chief Operating Officer